Aurinia Pharmaceuticals Inc. (AUPH) Net income 2018–2025
Aurinia Pharmaceuticals Inc. (AUPH) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$287.2MFY2025 · since FY2018: -$53.1M → $287.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $287.2M | +4851.7% |
| FY2024 | $5.8M | +107.4% |
| FY2023 | -$78.0M | +27.9% |
| FY2022 | -$108.2M | +40.2% |
| FY2021 | -$181.0M | -76.3% |
| FY2020 | -$102.7M | -16.2% |
| FY2019 | -$88.4M | -66.5% |
| FY2018 | -$53.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice